AI Reasoning for Biomedical vs. AI Reasoning for Commerce — Why Regulated Industries Pick the Wrong AI Bets

PerturbAI and OpenAI just released biomedical reasoning agents that run multi-step inference at research scale. Within a week, three telecom CXOs asked me if the same architecture could solve their churn-prediction and fraud-detection stack.

The answer is no — and the reason exposes why regulated industries keep burning budgets on the wrong AI bets.

Biomedical reasoning agents work because the training data is clean, the causal pathways are documented, and the margin for error is regulated. Commercial AI in telecom and fintech operates in the opposite environment: noisy transaction logs, unmapped customer journeys, and compliance frameworks that weren't written for probabilistic models.

You can't transplant a reasoning architecture built for controlled experiments into production environments where the data quality is three sigma below what the model expects.

The deck walks through the gap — and what it actually costs you.

#AIinTelecom #EnterpriseAI #ReasoningModels #AIinFintech #CommercialAI

📩 The full weekly breakdown lands in AI — Daily Brief → https://amplyfy.app/wire/subscribe/1